论文部分内容阅读
目的 :探究脑梗塞患者采用灯盏花素注射液治疗前后其MMSE积分、BBS积分及血脂水平的变化情况,分析其临床治疗效果。方法 :随机选取2013年12月~2014年12月期间在我院接受治疗的100例脑梗塞患者为研究对象,并将所选患者随机分为对照组和实验组,每组各50例,其中对照组患者给予右旋糖酐加丹参注射液治疗,对照组患者给予灯盏花素加葡萄糖注射液治疗,治疗一个月后,分别采用MMSE积分和BBS积分对两组患者进行认知功能和行为能力的客观评价,对比分析两组患者治疗前后的MMSE积分和BBS积分变化情况以及血脂水平的变化。结果 :实验组患者与对照组患者治疗前的MESS积分和BBS积分和血脂水平对比差异无统计学意义,两组治疗后的MESS积分和BBS积分和血脂水平对比差异显著,具有统计学意义。实验组患者的临床疗效(96%)明显优于对照组(86%),两组对比具有统计学意义。结论 :灯盏花素治疗脑梗塞具有良好的治疗效果,能够显著改善患者的MMSE积分和BBS积分变化情况以及血脂水平,值得临床推广。
Objective: To investigate the changes of MMSE score, BBS score and blood lipid level in patients with cerebral infarction before and after treatment with breviscapine injection, and to analyze its clinical effect. Methods: A total of 100 patients with cerebral infarction treated in our hospital from December 2013 to December 2014 were selected as the study subjects, and the patients were randomly divided into control group and experimental group, 50 cases in each group Patients in the control group were treated with dextran and Salviae Miltiorrhizae injection. Patients in the control group were treated with breviscapine plus glucose injection. One month after treatment, MMSE and BBS scores were used to evaluate the cognitive and behavioral abilities of both groups The changes of MMSE score, BBS score and blood lipid level before and after treatment were compared between the two groups. Results: There was no significant difference in MESS score, BBS score and blood lipid level between the experimental group and the control group before treatment. There was significant difference between the two groups in MESS score, BBS score and blood lipid level after treatment, with statistical significance. The clinical efficacy of the experimental group (96%) was significantly better than the control group (86%), the two groups were statistically significant. Conclusion: Breviscapine treatment of cerebral infarction has a good therapeutic effect, can significantly improve the patient’s MMSE score and BBS score changes and blood lipid levels, is worth clinical promotion.